Low-dose Aspirin No Longer Recommended to Prevent Cardiovascular Disease

Community NewsPublisher's Picks
569

Translate to Spanish or other 102 languages!

New draft recommendations from the U.S. Preventive Services Task Force recommend against taking aspirin to prevent heart attacks and strokes for most people. Image for illustration purposes.

Mega Doctor News

- Advertisement -

By University of California San Diego Health

New draft recommendations from the U.S. Preventive Services Task Force recommend against taking aspirin to prevent heart attacks and strokes for most people. The Oct. 12, 2021 guidelines are based on new evidence showing that the risks of daily low-dose aspirin — especially from stomach issues and bleeding in the brain due to falls — outweigh the benefits it provides in helping to prevent heart disease for persons 60 years and older.

For people 40 to 59, the task force found only a small net benefit to taking aspirin as a preventive medication.

- Advertisement -

Medical experts say no one currently taking aspirin should quit before consulting their doctor first because the drug still has an anti-inflammatory effect that may provide a net benefit to some patients.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Lactoferrin supplements could aid in the recovery of COVID19 & other Respiratory Tract Infections
Next article
Pioneering Transplant Surgeon Presented with AMA Scientific Achievement Award

More Articles

STHS Earns Another 5-Star Healthgrades Distinction for Hip Fracture Care

For the sixth consecutive year, STHS McAllen and STHS Edinburg have earned a Five-Star Rating for Hip Fracture Treatment from Healthgrades, one of the nation's leading resources for evaluating hospital performance.

Raising Awareness, One Step at a Time: STHS Edinburg Hosts Sept. 23 Walkathon

To raise awareness about the condition and encourage residents to take proactive steps toward better vascular health, the STHS Limb Salvage & Amputation Prevention Program will host the Step Out PAD Walkathon on Wednesday, September 23, 2026, at STHS Edinburg, from 6:30 to 7:30 p.m.

FDA Launches Expedited IND Pilot to Speed Up Clinical Trials

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot. Accelerating clinical trial timelines and eliminating regulatory hurdles to maintain American leadership in global medical innovation is a core priority for the Trump Administration.

Navigating Cardiovascular Health in Hispanic Communities

Cardiovascular disease is the leading cause of death for Hispanic and Latino people in the United States. But the challenges they face are hardly the whole story, say experts who helped write a new report on the heart health of these communities.
- Advertisement -